SGO White Paper on ovarian cancer: etiology, screening and surveillance.
about
A phase 2, single-arm study of an autologous dendritic cell treatment against mucin 1 in patients with advanced epithelial ovarian cancerEndometriosis: where are we and where are we going?Carboplatin with Decitabine Therapy, in Recurrent Platinum Resistant Ovarian Cancer, Alters Circulating miRNAs Concentrations: A Pilot StudyThe impact of risk-reducing hysterectomy and bilateral salpingo-oophorectomy on survival in patients with a history of breast cancer--a population-based data linkage study.Antagonism of Bcl-XL is necessary for synergy between carboplatin and BH3 mimetics in ovarian cancer cells.Evaluation of the antitumor activity of NOV202, a novel microtubule targeting and vascular disrupting agent.188Re-Liposome Can Induce Mitochondrial Autophagy and Reverse Drug Resistance for Ovarian Cancer: From Bench Evidence to Preliminary Clinical Proof-of-ConceptOvarian cancer screening practices of obstetricians and gynecologists in puerto ricoImpact and mechanistic role of oral contraceptive pills on the number and epithelial type of ovarian cortical inclusion cysts; a clinicopathology and immunohistochemical studyEpithelial ovarian cancer: An overview.Translational application of epigenetic alterations: ovarian cancer as a model.Cancer Risk Awareness and Concern among Women with a Family History of Breast or Ovarian Cancer.Cucurbit [7] uril encapsulated cisplatin overcomes resistance to cisplatin induced by Rab25 overexpression in an intraperitoneal ovarian cancer modelEstimation of heritability for nine common cancers using data from genome-wide association studies in Chinese population.The Angelina Jolie Effect in Jewish Law: Prophylactic Mastectomy and Oophorectomy in BRCA CarriersRisk-Reducing Strategies for Ovarian Cancer in BRCA Mutation Carriers: A Balancing Act.A branching process model of ovarian cancer.Predictors of mortality within 1 year after primary ovarian cancer surgery: a nationwide cohort study.Increase of Incidence and Mortality of Ovarian Cancer during 2003-2012 in Jiangsu Province, China.Incidence, pattern and management of ovarian cancer at a tertiary medical center in enugu, South East NigeriaInfluence of a novel histone deacetylase inhibitor panobinostat (LBH589) on the growth of ovarian cancer.Recent perspectives of epithelial ovarian carcinomaValue of symptom-triggered diagnostic evaluation for ovarian cancer.Psychological and Behavioral Impact of Participation in Ovarian Cancer Screening.Metabolomics in urogenital cancer.Understanding the cross-talk between ovarian tumors and immune cells: mechanisms for effective immunotherapies.Cancer testis antigens: novel biomarkers and targetable proteins for ovarian cancer.Biomarkers for early detection of ovarian cancer.Risk-benefit assessment of the combined oral contraceptive pill in women with a family history of female cancer.The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review.microRNA and Ovarian Cancer.Affective, cognitive and behavioral outcomes associated with a false positive ovarian cancer screening test result.An update on the role of PET/CT and PET/MRI in ovarian cancer.HO-3867, a STAT3 inhibitor induces apoptosis by inactivation of STAT3 activity in BRCA1-mutated ovarian cancer cells.Irregular menses predicts ovarian cancer: Prospective evidence from the Child Health and Development Studies.Development of an integrated support system for hereditary cancer and its impact on gynecologic services.Risk assessment for epithelial ovarian cancer: proposing a new approach to a deadly problem.Diagnostic potential for a serum miRNA neural network for detection of ovarian cancer.Demographic, clinical, dispositional, and social-environmental characteristics associated with psychological response to a false positive ovarian cancer screening test: a longitudinal study.Diagnostic imaging using positron emission tomography for gynecological malignancy.
P2860
Q22001066-00938FA3-D612-4614-8C75-AC7BE981209EQ26750772-CD80DF09-A01D-428B-8482-40DFEEDB5641Q28550381-99F66627-D7EB-4D50-B69B-E1C70D22A2E9Q30677729-680BDF73-31FE-48CB-A83D-A84FE864678FQ33431526-166849DC-3DE8-4AB0-B5F8-FC912D83113AQ33638100-E1F7715F-3D0C-4C5E-90C0-15AE25F87FAEQ33754754-66B4E216-9B23-4BF4-9F74-3422C4ABF3FAQ34406285-30480866-60DF-4B72-AF6A-32DBD44D2626Q34519259-F7C45745-61ED-4A00-A900-DA488945B4B7Q34708560-3D4921E7-19BA-4276-8AD7-6060301A7526Q35085782-47EC5B7E-2546-4D05-9157-D5386C7BEC78Q35748787-E425C04F-6EC2-408A-947D-809EB5FFB239Q36073949-66F3A49B-AEC5-4E4B-84A8-AC4FDF963D2CQ36144811-472659A3-E053-479C-8BF1-2372C809C9CBQ36218446-92E57024-E913-4671-9C11-BF07A66E478EQ36313479-1454ED43-0F09-4D9A-818D-83C34BD2A575Q36339013-B50F4A81-2576-44BA-9889-0F3997C18855Q36861215-7DEBFB88-94C5-40B2-9AB9-0D4FAF29B66AQ37072207-7A67161E-8904-4A9A-9242-2BECC5B0C1FEQ37222322-035D1434-F7DB-43C4-8C90-C6557C80014AQ37260402-3A245E0E-4F6A-4473-B6D0-0385819C6B68Q37406816-331920D0-B218-4814-82A0-A3007594ABE1Q37524514-E347C12A-B3F3-4DC5-9054-3FB2118FA0E7Q37729983-25333E4E-3E2D-4D63-8405-67D0401AB079Q37867682-46589878-6E0E-4CD4-8737-79E1AA56ABBFQ37873924-84B32DC3-290F-4F4C-BFC4-93491F870FB6Q37873930-95C3EB93-41AC-4356-9E75-AF6B9C48582FQ38087982-B763B321-7CB1-4002-A497-2AD8DF80B907Q38242066-4DB6751C-C85C-42A4-B2BC-3F47D020612FQ38653169-B95FCBA0-4E05-4ED1-9831-B4B00E193589Q38667018-32731A18-8DEA-4D9B-9E0D-083A81B1DA09Q38692120-4EF01D0B-9CA4-435C-9D14-48C9BE6D7035Q39127714-50995B6C-A3C1-4964-A03A-1CDC786CB66DQ39313548-1C640AD3-4F99-4A1C-A8ED-CEB172E25DCCQ40798586-5C613883-0890-4BDA-9757-54A3D153AA87Q43749121-3086C35D-A64D-4D31-B924-BB7CEB56AABEQ44306217-5C321E0F-82F8-4838-84E4-02379CF66919Q45944325-DA8D422D-A469-479C-960F-7302E81196C1Q47288755-79192152-C716-4C1A-AF1F-700B9DBB1D27Q48105266-7E3F2465-EF0D-46C2-A5CE-7D972E025AE9
P2860
SGO White Paper on ovarian cancer: etiology, screening and surveillance.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
SGO White Paper on ovarian cancer: etiology, screening and surveillance.
@ast
SGO White Paper on ovarian cancer: etiology, screening and surveillance.
@en
SGO White Paper on ovarian cancer: etiology, screening and surveillance.
@nl
type
label
SGO White Paper on ovarian cancer: etiology, screening and surveillance.
@ast
SGO White Paper on ovarian cancer: etiology, screening and surveillance.
@en
SGO White Paper on ovarian cancer: etiology, screening and surveillance.
@nl
prefLabel
SGO White Paper on ovarian cancer: etiology, screening and surveillance.
@ast
SGO White Paper on ovarian cancer: etiology, screening and surveillance.
@en
SGO White Paper on ovarian cancer: etiology, screening and surveillance.
@nl
P2093
P1433
P1476
SGO White Paper on ovarian cancer: etiology, screening and surveillance.
@en
P2093
John O Schorge
Linda R Duska
Robert L Coleman
Susan C Modesitt
Thomas J Herzog
P356
10.1016/J.YGYNO.2010.06.003
P407
P577
2010-08-07T00:00:00Z